title: [Gadolinium-DTPA as an oral contrast medium for MR tomography of the abdomen].
abstract: 150 MR examinations of the upper abdomen were carried out after the oral administration of 5 ml/kg body weight of a gadolinium DTPA formulation (1.0 mmol/l, 15 g/l mannitol), with reference to the delineation of the pancrease, the liver and intra-abdominal fat. For comparison, 100 MR examinations without oral opacification of the G.I. tract were evaluated. Contrast administration resulted in a signal-intensive demonstration of the G.I. tract for all measurement sequences. The intraluminal contrast improved the distinction between normal and abnormal structures. T1 and T2 sequences and the demonstration of fat on T2-weighted series. T1-weighted series showed the best diagnostic results. In 25% there was meteorism and diarrhoea within 24 hours of the administration of the oral contrast.
authors.affiliation: Institut für Röntgendiagnostik, Universität Würzburg.
authors.forename: T
authors.initials: T
authors.lastname: Krahe
authors.forename: W
authors.initials: W
authors.lastname: Dölken
authors.forename: K
authors.initials: K
authors.lastname: Lackner
authors.forename: M
authors.initials: M
authors.lastname: Houselog
authors.forename: W
authors.initials: W
authors.lastname: Habscheid
authors.forename: W
authors.initials: W
authors.lastname: Clauss
mesh_terms: D000005:Abdomen / Q000473:pathology*; D000284:Administration, Oral; D003287:Contrast Media / Q000008:administration & dosage*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005215:Fasting; D005260:Female; D005682:Gadolinium; D019786:Gadolinium DTPA; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA
vernacular_title: Gadolinium-DTPA als orales Kontrastmittel für die MR-Tomographie des Abdomens.